UCLA Radiation OncologyLos Angeles, CA
Disclosures:
247 - A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes
Monday, September 30, 20245:00 PM – 5:10 PM ET
3250 - Phase 2 Prospective Trial of Re-Treatment with 177lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration Resistant Prostate Cancer (RE-LuPSMA): Study Protocol
Tuesday, October 1, 20242:30 PM – 3:45 PM ET
337 - The Interplay between Acute and Late Toxicity among Patients Receiving Prostate Radiotherapy: A Pooled Analysis of 7 Randomized Trials
Wednesday, October 2, 20248:40 AM – 8:50 AM ET